Previous Article | Next Article ![]()
Journal of Virology, December 2001, p. 11874-11880, Vol. 75, No. 23
ABL-Basic Research
Program1 and HIV Drug Resistance
Program,3 National Cancer
Institute
Received 21 June 2001/Accepted 22 August 2001
The synthesis of retroviral DNA is initiated near the 5' end of the
RNA. DNA synthesis is transferred from the 5' end to the 3' end of
viral RNA in an RNase H-dependent step. In the case of human
immunodeficiency virus type 1 (HIV-1) (and certain other retroviruses
that have complex secondary structures at the ends of the viral RNA),
there is the possibility that DNA synthesis can lead to a self-priming
event that would block viral replication. The extent of RNase H
cleavage must be sufficient to allow the strand transfer reaction to
occur, but not so extensive that self-priming occurs. We have used a
series of model RNA substrates, with and without a 5' cap, to
investigate the rules governing RNase H cleavage at the 5' end of the
HIV-1 genome. These in vitro RNase H cleavage reactions produce an RNA
fragment of the size needed to block self-priming but still allow
strand transfer. The cleavages seen in vitro can be understood in light
of the structure of HIV-1 reverse transcriptase in a complex with an
RNA/DNA substrate.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.23.11874-11880.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
RNase H Cleavage of the 5' End of the Human
Immunodeficiency Virus Type 1 Genome

Frederick, Frederick, Maryland 21702-1201, and
Center for Advanced Biotechnology and Medicine and
Chemistry Department, Rutgers University, Piscataway, New Jersey
08854-56382
*
Corresponding author. Mailing address: HIV Drug
Resistance Program, National Cancer Institute-FCRDC, P.O. Box B,
Building 539, Room 130A, Frederick, MD 21702-1201 Phone: (301)
846-1619. Fax: (301) 846-6966. E-mail: hughes{at}ncifcrf.gov.
Present address: E-Centive, Bethesda, MD 20817.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|